Literature DB >> 33349842

Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.

Uladzislau Rudakou1,2, Eric Yu1,2, Lynne Krohn1,2, Jennifer A Ruskey2,3, Farnaz Asayesh2,3, Yves Dauvilliers4, Dan Spiegelman2,3, Lior Greenbaum5,6,7, Stanley Fahn8, Cheryl H Waters8, Nicolas Dupré9,10, Guy A Rouleau1,2,3, Sharon Hassin-Baer7,11,12, Edward A Fon2,3, Roy N Alcalay8,13, Ziv Gan-Or1,2,3.   

Abstract

Genome-wide association studies (GWAS) have identified numerous loci associated with Parkinson's disease. The specific genes and variants that drive the associations within the vast majority of these loci are unknown. We aimed to perform a comprehensive analysis of selected genes to determine the potential role of rare and common genetic variants within these loci. We fully sequenced 32 genes from 25 loci previously associated with Parkinson's disease in 2657 patients and 3647 controls from three cohorts. Capture was done using molecular inversion probes targeting the exons, exon-intron boundaries and untranslated regions (UTRs) of the genes of interest, followed by sequencing. Quality control was performed to include only high-quality variants. We examined the role of rare variants (minor allele frequency < 0.01) using optimized sequence Kernel association tests. The association of common variants was estimated using regression models adjusted for age, sex and ethnicity as required in each cohort, followed by a meta-analysis. After Bonferroni correction, we identified a burden of rare variants in SYT11, FGF20 and GCH1 associated with Parkinson's disease. Nominal associations were identified in 21 additional genes. Previous reports suggested that the SYT11 GWAS association is driven by variants in the nearby GBA gene. However, the association of SYT11 was mainly driven by a rare 3' UTR variant (rs945006601) and was independent of GBA variants (P = 5.23 × 10-5 after exclusion of all GBA variant carriers). The association of FGF20 was driven by a rare 5' UTR variant (rs1034608171) located in the promoter region. The previously reported association of GCH1 with Parkinson's disease is driven by rare non-synonymous variants, some of which are known to cause dopamine-responsive dystonia. We also identified two LRRK2 variants, p.Arg793Met and p.Gln1353Lys, in 10 and eight controls, respectively, but not in patients. We identified common variants associated with Parkinson's disease in MAPT, TMEM175, BST1, SNCA and GPNMB, which are all in strong linkage disequilibrium with known GWAS hits in their respective loci. A common coding PM20D1 variant, p.Ile149Val, was nominally associated with reduced risk of Parkinson's disease (odds ratio 0.73, 95% confidence interval 0.60-0.89, P = 1.161 × 10-3). This variant is not in linkage disequilibrium with the top GWAS hits within this locus and may represent a novel association. These results further demonstrate the importance of fine mapping of GWAS loci, and suggest that SYT11, FGF20, and potentially PM20D1, BST1 and GPNMB should be considered for future studies as possible Parkinson's disease-related genes.
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Parkinson’s disease; association study; genetic fine mapping; risk loci; sequencing

Mesh:

Substances:

Year:  2021        PMID: 33349842      PMCID: PMC7940168          DOI: 10.1093/brain/awaa401

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  75 in total

1.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

2.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

3.  Diagnostic exome sequencing in early-onset Parkinson's disease confirms VPS13C as a rare cause of autosomal-recessive Parkinson's disease.

Authors:  B Schormair; D Kemlink; B Mollenhauer; O Fiala; G Machetanz; J Roth; R Berutti; T M Strom; B Haslinger; C Trenkwalder; D Zahorakova; P Martasek; E Ruzicka; J Winkelmann
Journal:  Clin Genet       Date:  2018-01-24       Impact factor: 4.438

4.  Identification of a large homozygous VPS13C deletion in a patient with early-onset Parkinsonism.

Authors:  Hossein Darvish; Paloma Bravo; Abbas Tafakhori; Luis J Azcona; Sakineh Ranji-Burachaloo; Amir Hossein Johari; Coro Paisán-Ruiz
Journal:  Mov Disord       Date:  2018-11-19       Impact factor: 10.338

5.  RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.

Authors:  David A MacLeod; Herve Rhinn; Tomoki Kuwahara; Ari Zolin; Gilbert Di Paolo; Brian D McCabe; Brian D MacCabe; Karen S Marder; Lawrence S Honig; Lorraine N Clark; Scott A Small; Asa Abeliovich
Journal:  Neuron       Date:  2013-02-06       Impact factor: 17.173

6.  Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.

Authors:  Michael A Nalls; Vincent Plagnol; Dena G Hernandez; Manu Sharma; Una-Marie Sheerin; Mohamad Saad; J Simón-Sánchez; Claudia Schulte; Suzanne Lesage; Sigurlaug Sveinbjörnsdóttir; Kári Stefánsson; Maria Martinez; John Hardy; Peter Heutink; Alexis Brice; Thomas Gasser; Andrew B Singleton; Nicholas W Wood
Journal:  Lancet       Date:  2011-02-01       Impact factor: 79.321

7.  Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.

Authors:  Iris E Jansen; Hui Ye; Sasja Heetveld; Marie C Lechler; Helen Michels; Renée I Seinstra; Steven J Lubbe; Valérie Drouet; Suzanne Lesage; Elisa Majounie; J Raphael Gibbs; Mike A Nalls; Mina Ryten; Juan A Botia; Jana Vandrovcova; Javier Simon-Sanchez; Melissa Castillo-Lizardo; Patrizia Rizzu; Cornelis Blauwendraat; Amit K Chouhan; Yarong Li; Puja Yogi; Najaf Amin; Cornelia M van Duijn; Huw R Morris; Alexis Brice; Andrew B Singleton; Della C David; Ellen A Nollen; Shushant Jain; Joshua M Shulman; Peter Heutink
Journal:  Genome Biol       Date:  2017-01-30       Impact factor: 13.583

8.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

9.  Coding variation in GBA explains the majority of the SYT11-GBA Parkinson's disease GWAS locus.

Authors:  Cornelis Blauwendraat; Jose M Bras; Mike A Nalls; Patrick A Lewis; Dena G Hernandez; Andrew B Singleton
Journal:  Mov Disord       Date:  2018-10-09       Impact factor: 10.338

10.  Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.

Authors:  Suzanne Lesage; Valérie Drouet; Elisa Majounie; Vincent Deramecourt; Maxime Jacoupy; Aude Nicolas; Florence Cormier-Dequaire; Sidi Mohamed Hassoun; Claire Pujol; Sorana Ciura; Zoi Erpapazoglou; Tatiana Usenko; Claude-Alain Maurage; Mourad Sahbatou; Stefan Liebau; Jinhui Ding; Basar Bilgic; Murat Emre; Nihan Erginel-Unaltuna; Gamze Guven; François Tison; Christine Tranchant; Marie Vidailhet; Jean-Christophe Corvol; Paul Krack; Anne-Louise Leutenegger; Michael A Nalls; Dena G Hernandez; Peter Heutink; J Raphael Gibbs; John Hardy; Nicholas W Wood; Thomas Gasser; Alexandra Durr; Jean-François Deleuze; Meriem Tazir; Alain Destée; Ebba Lohmann; Edor Kabashi; Andrew Singleton; Olga Corti; Alexis Brice
Journal:  Am J Hum Genet       Date:  2016-03-03       Impact factor: 11.025

View more
  11 in total

1.  Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes.

Authors:  Meiqin Hu; Ping Li; Ce Wang; Xinghua Feng; Qi Geng; Wei Chen; Matangi Marthi; Wenlong Zhang; Chenlang Gao; Whitney Reid; Joel Swanson; Wanlu Du; Richard I Hume; Haoxing Xu
Journal:  Cell       Date:  2022-06-23       Impact factor: 66.850

2.  Genetic Analysis of Six Transmembrane Protein Family Genes in Parkinson's Disease in a Large Chinese Cohort.

Authors:  Yuwen Zhao; Kailin Zhang; Hongxu Pan; Yige Wang; Xiaoxia Zhou; Yaqin Xiang; Qian Xu; Qiying Sun; Jieqiong Tan; Xinxiang Yan; Jinchen Li; Jifeng Guo; Beisha Tang; Zhenhua Liu
Journal:  Front Aging Neurosci       Date:  2022-07-04       Impact factor: 5.702

3.  Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.

Authors:  Wei Quan; Jia Li; Li Liu; Qinghui Zhang; Yidan Qin; Xiaochen Pei; Jiajun Chen
Journal:  Neurol Sci       Date:  2021-11-29       Impact factor: 3.830

4.  Long non-coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p/GPNMB axis in Parkinson's disease cell model.

Authors:  Kefeng Lv; Yuhua Liu; Yanbing Zheng; Shaowen Dai; Peifeng Yin; Haifeng Miao
Journal:  Biol Res       Date:  2021-03-16       Impact factor: 5.612

5.  Association analysis of SYT11, FGF20, GCH1 rare variants in Parkinson's disease.

Authors:  Jia-Li Pu; Zhi-Hao Lin; Ran Zheng; Yi-Qun Yan; Nai-Jia Xue; Xin-Zhen Yin; Bao-Rong Zhang
Journal:  CNS Neurosci Ther       Date:  2021-10-21       Impact factor: 5.243

Review 6.  Crosstalk of organelles in Parkinson's disease - MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes.

Authors:  Martin Lang; Peter P Pramstaller; Irene Pichler
Journal:  Mol Neurodegener       Date:  2022-07-16       Impact factor: 18.879

7.  Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD Consortium.

Authors:  Sandeep Grover; Ashwin Ashok Kumar Sreelatha; Lasse Pihlstrom; Cloé Domenighetti; Claudia Schulte; Pierre-Emmanuel Sugier; Milena Radivojkov-Blagojevic; Peter Lichtner; Océane Mohamed; Berta Portugal; Zied Landoulsi; Patrick May; Dheeraj Bobbili; Connor Edsall; Felix Bartusch; Maximilian Hanussek; Jens Krüger; Dena G Hernandez; Cornelis Blauwendraat; George D Mellick; Alexander Zimprich; Walter Pirker; Manuela Tan; Ekaterina Rogaeva; Anthony Lang; Sulev Koks; Pille Taba; Suzanne Lesage; Alexis Brice; Jean-Christophe Corvol; Marie-Christine Chartier-Harlin; Eugenie Mutez; Kathrin Brockmann; Angela B Deutschländer; Georges M Hadjigeorgiou; Efthimos Dardiotis; Leonidas Stefanis; Athina Maria Simitsi; Enza Maria Valente; Simona Petrucci; Letizia Straniero; Anna Zecchinelli; Gianni Pezzoli; Laura Brighina; Carlo Ferrarese; Grazia Annesi; Andrea Quattrone; Monica Gagliardi; Lena F Burbulla; Hirotaka Matsuo; Yusuke Kawamura; Nobutaka Hattori; Kenya Nishioka; Sun Ju Chung; Yun Joong Kim; Lukas Pavelka; Bart P C van de Warrenburg; Bastiaan R Bloem; Andrew B Singleton; Jan Aasly; Mathias Toft; Leonor Correia Guedes; Joaquim J Ferreira; Soraya Bardien; Jonathan Carr; Eduardo Tolosa; Mario Ezquerra; Pau Pastor; Monica Diez-Fairen; Karin Wirdefeldt; Nancy L Pedersen; Caroline Ran; Andrea C Belin; Andreas Puschmann; Clara Hellberg; Carl E Clarke; Karen E Morrison; Dimitri Krainc; Matt J Farrer; Rejko Kruger; Alexis Elbaz; Thomas Gasser; Manu Sharma
Journal:  Neurology       Date:  2022-05-26       Impact factor: 11.800

8.  Can PM20D1 be a New Kid on the Block in Cardiovascular Risk Stratification? Do Not Run before You Can Walk.

Authors:  Ana Teresa Timóteo
Journal:  Arq Bras Cardiol       Date:  2022-09       Impact factor: 2.667

Review 9.  The Genetics of Parkinson's Disease and Implications for Clinical Practice.

Authors:  Jacob Oliver Day; Stephen Mullin
Journal:  Genes (Basel)       Date:  2021-06-30       Impact factor: 4.096

10.  SNCA 3' UTR Genetic Variants in Patients with Parkinson's Disease.

Authors:  Antonela Blažeković; Kristina Gotovac Jerčić; Fran Borovečki
Journal:  Biomolecules       Date:  2021-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.